| Seacoast Medical Care, P.a. | |
|
57 Barra Rd Suite #1 Biddeford ME 04005-9448 | |
| (207) 286-3504 | |
| (207) 286-3767 |
| Full Name | Seacoast Medical Care, P.a. |
|---|---|
| Speciality | Internal Medicine |
| Location | 57 Barra Rd, Biddeford, Maine |
| Authorized Official Name and Position | Woodrow Davis Lee (PRESIDENT) |
| Authorized Official Contact | 2072863504 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Seacoast Medical Care, P.a. 57 Barra Rd Suite #1 Biddeford ME 04005-9448 Ph: (207) 286-3504 | Seacoast Medical Care, P.a. 57 Barra Rd Suite #1 Biddeford ME 04005-9448 Ph: (207) 286-3504 |
| NPI Number | 1467527705 |
|---|---|
| Provider Enumeration Date | 11/22/2006 |
| Last Update Date | 08/19/2008 |
| Medicare PECOS PAC ID | 6901973742 |
|---|---|
| Medicare Enrollment ID | O20080922000153 |
News Archive
In March, New Hampshire preschool teacher Gail O'Brien, who was unable to obtain health insurance through her employer, was diagnosed with an aggressive form of lymphoma. Her subsequent applications for health insurance were rejected because of her condition. With each round of chemotherapy costing $16,000, she delayed treatment because she knew her savings wouldn't last (Eric H. Holder and Kathleen Sebelius, 12/14).
Improving care for depression in low-income communities - places where such help is frequently unavailable or hard to find - provides greater benefits to those in need when community groups such as churches and even barber shops help lead the planning process, according to a new study.
A team of University of Florida researchers has created tiny hybrid particles that can speedily root out even one isolated E. coli bacterium lurking in ground beef or provide a crucial early warning alarm for bacteria used as agents of bioterrorism and for early disease diagnosis.
Naurex Inc., a new clinical stage company developing innovative treatments for depression and other CNS disorders based on its novel GFPA NMDA receptor modulators, today announced that data presented at a major medical meeting showed that its lead compound GLYX-13 demonstrated robust antidepressant-like and anxiolytic-like activity with no signs of the CNS-related side effects seen with other drugs targeting the NMDA receptor.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467527705 | NPI | - | NPPES |
| 2732880 | Other | ME | AETNA |
| M214470 | Other | ME | CIGNA |
| 174560000 | Medicaid | ME |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| Provider Name | Maureen T Lee |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1275635781 PECOS PAC ID: 4284664392 Enrollment ID: I20050818000415 |
News Archive
In March, New Hampshire preschool teacher Gail O'Brien, who was unable to obtain health insurance through her employer, was diagnosed with an aggressive form of lymphoma. Her subsequent applications for health insurance were rejected because of her condition. With each round of chemotherapy costing $16,000, she delayed treatment because she knew her savings wouldn't last (Eric H. Holder and Kathleen Sebelius, 12/14).
Improving care for depression in low-income communities - places where such help is frequently unavailable or hard to find - provides greater benefits to those in need when community groups such as churches and even barber shops help lead the planning process, according to a new study.
A team of University of Florida researchers has created tiny hybrid particles that can speedily root out even one isolated E. coli bacterium lurking in ground beef or provide a crucial early warning alarm for bacteria used as agents of bioterrorism and for early disease diagnosis.
Naurex Inc., a new clinical stage company developing innovative treatments for depression and other CNS disorders based on its novel GFPA NMDA receptor modulators, today announced that data presented at a major medical meeting showed that its lead compound GLYX-13 demonstrated robust antidepressant-like and anxiolytic-like activity with no signs of the CNS-related side effects seen with other drugs targeting the NMDA receptor.
› Verified 7 days ago
| Provider Name | Woodrow D Lee |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1902908411 PECOS PAC ID: 6901836014 Enrollment ID: I20050818000425 |
News Archive
In March, New Hampshire preschool teacher Gail O'Brien, who was unable to obtain health insurance through her employer, was diagnosed with an aggressive form of lymphoma. Her subsequent applications for health insurance were rejected because of her condition. With each round of chemotherapy costing $16,000, she delayed treatment because she knew her savings wouldn't last (Eric H. Holder and Kathleen Sebelius, 12/14).
Improving care for depression in low-income communities - places where such help is frequently unavailable or hard to find - provides greater benefits to those in need when community groups such as churches and even barber shops help lead the planning process, according to a new study.
A team of University of Florida researchers has created tiny hybrid particles that can speedily root out even one isolated E. coli bacterium lurking in ground beef or provide a crucial early warning alarm for bacteria used as agents of bioterrorism and for early disease diagnosis.
Naurex Inc., a new clinical stage company developing innovative treatments for depression and other CNS disorders based on its novel GFPA NMDA receptor modulators, today announced that data presented at a major medical meeting showed that its lead compound GLYX-13 demonstrated robust antidepressant-like and anxiolytic-like activity with no signs of the CNS-related side effects seen with other drugs targeting the NMDA receptor.
› Verified 7 days ago
News Archive
In March, New Hampshire preschool teacher Gail O'Brien, who was unable to obtain health insurance through her employer, was diagnosed with an aggressive form of lymphoma. Her subsequent applications for health insurance were rejected because of her condition. With each round of chemotherapy costing $16,000, she delayed treatment because she knew her savings wouldn't last (Eric H. Holder and Kathleen Sebelius, 12/14).
Improving care for depression in low-income communities - places where such help is frequently unavailable or hard to find - provides greater benefits to those in need when community groups such as churches and even barber shops help lead the planning process, according to a new study.
A team of University of Florida researchers has created tiny hybrid particles that can speedily root out even one isolated E. coli bacterium lurking in ground beef or provide a crucial early warning alarm for bacteria used as agents of bioterrorism and for early disease diagnosis.
Naurex Inc., a new clinical stage company developing innovative treatments for depression and other CNS disorders based on its novel GFPA NMDA receptor modulators, today announced that data presented at a major medical meeting showed that its lead compound GLYX-13 demonstrated robust antidepressant-like and anxiolytic-like activity with no signs of the CNS-related side effects seen with other drugs targeting the NMDA receptor.
› Verified 7 days ago
Michael J Quigley Md Pa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 357 Elm St, Biddeford, ME 04005 Phone: 207-282-5919 | |
Smhc Physician Services Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr, Biddeford, ME 04005 Phone: 207-283-7000 | |
Seacoast Medical Care Pa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 57 Barra Rd, Suite #1, Biddeford, ME 04005 Phone: 207-286-3504 Fax: 207-286-3767 | |
Nasson Health Care-mbh-biddeford Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2 Springbrook Dr, Biddeford, ME 04005 Phone: 207-490-6900 Fax: 207-324-0546 | |
Wellspring Family Medical Associates, Pa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4 Wellspring Rd, Biddeford, ME 04005 Phone: 207-282-3369 Fax: 207-282-9920 | |
Bene Esse, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 28 W Cole Rd Ste 105, Biddeford, ME 04005 Phone: 207-324-5968 Fax: 888-519-0831 | |
York County Community Action Corp Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 357 Elm St, Biddeford, ME 04005 Phone: 207-490-6900 Fax: 207-324-0546 |